Ramakrishna Battini MD
Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Oncologist/ Hematologist
Join to view full profile
7945 Wolf River BlvdGermantown, TN 38138
Phone+1 901-683-0055
Dr. Battini is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ramakrishna Battini is a skilled Oncologist based in Germantown, TN, currently working at the West Cancer Center. With subspecialties in Gastrointestinal Cancer, Hematologic Oncology, and Thoracic Cancer, Dr. Battini is especially experienced in treating gastrointestinal and lung cancers. His oncology career began at Montefiore Medical Center, following his Internal Medicine Residency and Hematology and Medical Oncology Fellowship at the same institution. Dr. Battini is also an active contributor to his field, with several publications on topics ranging from specific mutations to novel treatment methods. Additionally, he has been involved in clinical trials aiming to treat different forms of Lymphoma and leukemia. He graduated from Guntur Medical College NTR in 2002.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2009 - 2012- Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Residency, Internal Medicine, 2006 - 2009
Guntur Medical College NTRClass of 2002
Certifications & Licensure
MS State Medical License 2017 - 2027
TN State Medical License 2016 - 2027
NY State Medical License 2009 - 2016
OH State Medical License 2012 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
- ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Start of enrollment: 2013 Jan 31
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Publications & Presentations
PubMed
- 3 citationsAlectinib-associated pneumoperitoneum in stage IV non-small cell lung cancer - A case report.Renee M Maina, Caroline A Rader, Clarisse S Muenyi, Ramakrishna Battini, Nia N Zalamea
Annals of Medicine and Surgery. 2022-10-01 - 7 citationsPharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma.Stefan K. Barta, Rishi Jain, Amithaba Mazumder, Jason Carter, Lawrence Almanzar
Clinical Lymphoma, Myeloma & Leukemia. 2017-10-01 - 10 citationsStimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: A pilot study.Aditi Shastri, Anjali Budhathoki, Stefan K. Barta, Noah Kornblum, Olga Derman
American Journal of Hematology. 2017-07-04
Press Mentions
Regional One Health Pushes Past 'Trauma-Only' Reputation with Advancements in Cancer TreatmentDecember 30th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: